Locoregional Treatment in Patients With Metastatic Cervical Cancer: Benefit of Dose Escalation Strategies-Reference-Cited by-同舟云学术

Locoregional Treatment in Patients With Metastatic Cervical Cancer: Benefit of Dose Escalation Strategies

Published:2024-01 Issue:1 Volume:118 Page:192-202
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Laville Adrien^ORCID,Ka Kanta,El-Ayachi Radouane,Achkar Samir,Bockel Sophie,Gouy Sébastien,Espenel Sophie,Morice Philippe,Sun Roger,Pautier Patricia,Chargari Cyrus

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference31 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis;Arbyn;Lancet Glob Health,2020

3. SEER*Explorer Application, accessed 10 May 2023, https://seer.cancer.gov/

4. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: A Gynecologic Oncology Group study;Monk;J Clin Oncol,2009

5. Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: The open-label randomized phase III trial JCOG0505;Kitagawa;J Clin Oncol,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term survival in patients with para-aortic metastatic cervical cancer receiving simultaneous integrated boost chemoradiation to positive lymph nodes: a single-center experience;International Journal of Gynecologic Cancer;2024-08-28